

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | regulation of vitamin D biosynthetic process (GO:0060556) | 5.41042839 |
| 2 | negative regulation of interleukin-12 production (GO:0032695) | 4.37779188 |
| 3 | positive regulation of chemokine biosynthetic process (GO:0045080) | 4.28920951 |
| 4 | cellular response to arsenic-containing substance (GO:0071243) | 4.20538532 |
| 5 | regulation of vitamin metabolic process (GO:0030656) | 4.12767934 |
| 6 | negative regulation of nitric oxide biosynthetic process (GO:0045019) | 3.83233481 |
| 7 | response to xenobiotic stimulus (GO:0009410) | 3.77387268 |
| 8 | regulation of somitogenesis (GO:0014807) | 3.76223477 |
| 9 | negative regulation of retinoic acid receptor signaling pathway (GO:0048387) | 3.72619319 |
| 10 | regulation of chemokine biosynthetic process (GO:0045073) | 3.67871718 |
| 11 | oligosaccharide catabolic process (GO:0009313) | 3.67476019 |
| 12 | regulation of cytokine secretion involved in immune response (GO:0002739) | 3.63990715 |
| 13 | regulation of podosome assembly (GO:0071801) | 3.58528895 |
| 14 | regulation of chronic inflammatory response (GO:0002676) | 3.50986474 |
| 15 | cellular response to type I interferon (GO:0071357) | 3.50359641 |
| 16 | type I interferon signaling pathway (GO:0060337) | 3.50359641 |
| 17 | positive regulation of heat generation (GO:0031652) | 3.49366036 |
| 18 | positive regulation of lymphocyte apoptotic process (GO:0070230) | 3.48479306 |
| 19 | response to type I interferon (GO:0034340) | 3.46491809 |
| 20 | regulation of RIG-I signaling pathway (GO:0039535) | 3.38906246 |
| 21 | negative regulation of inflammatory response to antigenic stimulus (GO:0002862) | 3.30349354 |
| 22 | NIK/NF-kappaB signaling (GO:0038061) | 3.28782730 |
| 23 | regulation of interleukin-12 biosynthetic process (GO:0045075) | 3.26437501 |
| 24 | amino sugar catabolic process (GO:0046348) | 3.25689418 |
| 25 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 3.23613304 |
| 26 | branching involved in labyrinthine layer morphogenesis (GO:0060670) | 3.22037372 |
| 27 | negative regulation of endoplasmic reticulum calcium ion concentration (GO:0032471) | 3.20847664 |
| 28 | response to peptidoglycan (GO:0032494) | 3.19979205 |
| 29 | glycosphingolipid catabolic process (GO:0046479) | 3.19127018 |
| 30 | regulation of retinoic acid receptor signaling pathway (GO:0048385) | 3.15147515 |
| 31 | positive regulation of NF-kappaB import into nucleus (GO:0042346) | 3.14195745 |
| 32 | regulation of fever generation (GO:0031620) | 3.12573578 |
| 33 | positive regulation of interferon-beta production (GO:0032728) | 3.12032772 |
| 34 | eosinophil chemotaxis (GO:0048245) | 3.07298274 |
| 35 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 3.06118900 |
| 36 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 3.06118900 |
| 37 | positive regulation of interferon-alpha production (GO:0032727) | 3.04745258 |
| 38 | positive regulation by symbiont of host defense response (GO:0052509) | 3.04371719 |
| 39 | modulation by symbiont of host defense response (GO:0052031) | 3.04371719 |
| 40 | modulation by organism of immune response of other organism involved in symbiotic interaction (GO:00 | 3.04371719 |
| 41 | modulation by organism of defense response of other organism involved in symbiotic interaction (GO:0 | 3.04371719 |
| 42 | positive regulation by organism of defense response of other organism involved in symbiotic interact | 3.04371719 |
| 43 | modulation by symbiont of host immune response (GO:0052553) | 3.04371719 |
| 44 | response to interferon-beta (GO:0035456) | 3.02661887 |
| 45 | regulation of membrane protein ectodomain proteolysis (GO:0051043) | 2.97872536 |
| 46 | positive regulation of prostaglandin secretion (GO:0032308) | 2.96503067 |
| 47 | antigen processing and presentation of endogenous antigen (GO:0019883) | 2.96340994 |
| 48 | response to muramyl dipeptide (GO:0032495) | 2.93452430 |
| 49 | decidualization (GO:0046697) | 2.90305210 |
| 50 | negative regulation of cytokine production involved in immune response (GO:0002719) | 2.89452743 |
| 51 | positive regulation of membrane protein ectodomain proteolysis (GO:0051044) | 2.88740582 |
| 52 | immunoglobulin mediated immune response (GO:0016064) | 2.88287283 |
| 53 | regulation of immunoglobulin secretion (GO:0051023) | 2.87864029 |
| 54 | regulation of interferon-alpha production (GO:0032647) | 2.87236479 |
| 55 | N-acetylneuraminate metabolic process (GO:0006054) | 2.85329027 |
| 56 | membrane lipid catabolic process (GO:0046466) | 2.84957880 |
| 57 | defense response to protozoan (GO:0042832) | 2.84887667 |
| 58 | interferon-gamma-mediated signaling pathway (GO:0060333) | 2.84187523 |
| 59 | response to arsenic-containing substance (GO:0046685) | 2.83955402 |
| 60 | glycolipid catabolic process (GO:0019377) | 2.83874636 |
| 61 | regulation of viral-induced cytoplasmic pattern recognition receptor signaling pathway (GO:0039531) | 2.83046984 |
| 62 | regulation of T-helper 1 cell differentiation (GO:0045625) | 2.81099739 |
| 63 | sphingosine metabolic process (GO:0006670) | 2.79408459 |
| 64 | lipoxygenase pathway (GO:0019372) | 2.79212587 |
| 65 | sphingolipid catabolic process (GO:0030149) | 2.78841670 |
| 66 | ribosomal small subunit assembly (GO:0000028) | 2.77547505 |
| 67 | positive regulation of interleukin-6 production (GO:0032755) | 2.76813935 |
| 68 | regulation of nitric oxide biosynthetic process (GO:0045428) | 2.76532632 |
| 69 | positive regulation of monocyte chemotaxis (GO:0090026) | 2.76307639 |
| 70 | regulation of heat generation (GO:0031650) | 2.74978900 |
| 71 | negative regulation of lipid storage (GO:0010888) | 2.74352441 |
| 72 | lipopolysaccharide-mediated signaling pathway (GO:0031663) | 2.71727755 |
| 73 | myeloid dendritic cell differentiation (GO:0043011) | 2.69704517 |
| 74 | myeloid dendritic cell activation (GO:0001773) | 2.69325649 |
| 75 | adhesion of symbiont to host cell (GO:0044650) | 2.68180086 |
| 76 | virion attachment to host cell (GO:0019062) | 2.68180086 |
| 77 | negative regulation of lipopolysaccharide-mediated signaling pathway (GO:0031665) | 2.67616413 |
| 78 | regulation of inflammatory response to antigenic stimulus (GO:0002861) | 2.67480294 |
| 79 | wound healing, spreading of epidermal cells (GO:0035313) | 2.67040090 |
| 80 | ceramide catabolic process (GO:0046514) | 2.66169226 |
| 81 | cellular response to interferon-beta (GO:0035458) | 2.66057784 |
| 82 | regulation of interleukin-6 production (GO:0032675) | 2.65689844 |
| 83 | G-protein coupled purinergic nucleotide receptor signaling pathway (GO:0035589) | 2.65527850 |
| 84 | hepatocyte apoptotic process (GO:0097284) | 2.64970978 |
| 85 | positive regulation of p38MAPK cascade (GO:1900745) | 2.64183300 |
| 86 | eosinophil migration (GO:0072677) | 2.63789542 |
| 87 | response to interferon-alpha (GO:0035455) | 2.63103344 |
| 88 | positive regulation of antigen processing and presentation (GO:0002579) | 2.62535981 |
| 89 | response to progesterone (GO:0032570) | 2.62456081 |
| 90 | endothelial tube morphogenesis (GO:0061154) | 2.62138924 |
| 91 | morphogenesis of an endothelium (GO:0003159) | 2.62138924 |
| 92 | cellular response to virus (GO:0098586) | 2.62089336 |
| 93 | regulation of B cell receptor signaling pathway (GO:0050855) | 2.61313545 |
| 94 | positive regulation of nitric-oxide synthase biosynthetic process (GO:0051770) | 2.61135750 |
| 95 | diol metabolic process (GO:0034311) | 2.60600495 |
| 96 | neutrophil activation involved in immune response (GO:0002283) | 2.59697485 |
| 97 | granulocyte activation (GO:0036230) | 2.56729293 |
| 98 | regulation of prostaglandin secretion (GO:0032306) | 2.55371615 |
| 99 | regulation of interleukin-12 production (GO:0032655) | 2.55047813 |
| 100 | negative regulation of toll-like receptor 4 signaling pathway (GO:0034144) | 2.54645349 |
| 101 | regulation of dendritic cell antigen processing and presentation (GO:0002604) | 2.54550726 |
| 102 | germinal center formation (GO:0002467) | 2.54038394 |
| 103 | T cell apoptotic process (GO:0070231) | 2.53554219 |
| 104 | negative regulation of tumor necrosis factor production (GO:0032720) | 2.53065418 |
| 105 | positive regulation of leukocyte apoptotic process (GO:2000108) | 2.52937192 |
| 106 | regulation of interferon-beta biosynthetic process (GO:0045357) | 2.52571939 |
| 107 | regulation of mononuclear cell migration (GO:0071675) | 2.51978255 |
| 108 | regulation of NF-kappaB import into nucleus (GO:0042345) | 2.51684074 |
| 109 | cellular response to lipopolysaccharide (GO:0071222) | 2.50863103 |
| 110 | regulation of T cell chemotaxis (GO:0010819) | 2.50476573 |
| 111 | positive regulation of T cell chemotaxis (GO:0010820) | 2.50476573 |
| 112 | positive regulation of nitric oxide biosynthetic process (GO:0045429) | 2.50275894 |
| 113 | production of molecular mediator involved in inflammatory response (GO:0002532) | 2.50042726 |
| 114 | activation of MAPKKK activity (GO:0000185) | 2.49821023 |
| 115 | glomerular visceral epithelial cell development (GO:0072015) | 2.48985884 |
| 116 | positive regulation of gamma-delta T cell activation (GO:0046645) | 2.48122876 |
| 117 | positive regulation of syncytium formation by plasma membrane fusion (GO:0060143) | 2.47911069 |
| 118 | regulation of interferon-beta production (GO:0032648) | 2.47773702 |
| 119 | negative regulation of myeloid cell apoptotic process (GO:0033033) | 2.47484131 |
| 120 | regulation of response to interferon-gamma (GO:0060330) | 2.46888720 |
| 121 | negative regulation of interleukin-6 production (GO:0032715) | 2.45121531 |
| 122 | cellular response to thyroid hormone stimulus (GO:0097067) | 2.44935761 |
| 123 | monocyte chemotaxis (GO:0002548) | 2.43684432 |
| 124 | negative regulation of mast cell activation (GO:0033004) | 2.43444493 |
| 125 | low-density lipoprotein particle clearance (GO:0034383) | 2.43337925 |
| 126 | negative regulation of tumor necrosis factor superfamily cytokine production (GO:1903556) | 2.43190559 |
| 127 | response to laminar fluid shear stress (GO:0034616) | 2.41560004 |
| 128 | cellular response to molecule of bacterial origin (GO:0071219) | 2.41434445 |
| 129 | positive regulation of tumor necrosis factor biosynthetic process (GO:0042535) | 2.41383085 |
| 130 | regulation of toll-like receptor 4 signaling pathway (GO:0034143) | 2.40750023 |
| 131 | positive regulation of calcium ion import (GO:0090280) | 2.40090061 |
| 132 | modulation by symbiont of host cellular process (GO:0044068) | 2.39968962 |
| 133 | sphingoid metabolic process (GO:0046519) | 2.39522894 |
| 134 | endothelial cell chemotaxis (GO:0035767) | 2.39227673 |
| 135 | regulation of type I interferon-mediated signaling pathway (GO:0060338) | 2.39111053 |
| 136 | positive regulation of interleukin-12 production (GO:0032735) | 2.39066878 |
| 137 | regulation of apoptotic process involved in morphogenesis (GO:1902337) | 2.38506434 |
| 138 | regulation of lipopolysaccharide-mediated signaling pathway (GO:0031664) | 2.37971458 |
| 139 | regulation of antigen processing and presentation (GO:0002577) | 2.37175410 |
| 140 | positive regulation of type I interferon production (GO:0032481) | 2.37121217 |
| 141 | positive regulation of T cell migration (GO:2000406) | 2.35929045 |
| 142 | leukocyte apoptotic process (GO:0071887) | 2.34613890 |
| 143 | cellular response to interferon-alpha (GO:0035457) | 2.33563128 |
| 144 | heparin metabolic process (GO:0030202) | 2.31759497 |
| 145 | heparin biosynthetic process (GO:0030210) | 2.31759497 |
| 146 | positive regulation of natural killer cell differentiation (GO:0032825) | 2.31654657 |
| 147 | chaperone mediated protein folding requiring cofactor (GO:0051085) | 2.31180214 |
| 148 | positive regulation of protein homooligomerization (GO:0032464) | 2.30955631 |
| 149 | negative regulation of viral genome replication (GO:0045071) | 2.30547628 |
| 150 | natural killer cell mediated cytotoxicity (GO:0042267) | 2.29903427 |
| 151 | natural killer cell mediated immunity (GO:0002228) | 2.29903427 |
| 152 | I-kappaB kinase/NF-kappaB signaling (GO:0007249) | 2.29146454 |
| 153 | regulation of protein import into nucleus, translocation (GO:0033158) | 2.28923512 |
| 154 | regulation of interferon-gamma-mediated signaling pathway (GO:0060334) | 2.28175173 |
| 155 | regulation of T cell migration (GO:2000404) | 2.27702567 |
| 156 | positive regulation of antigen receptor-mediated signaling pathway (GO:0050857) | 2.27173743 |
| 157 | wound healing, spreading of cells (GO:0044319) | 2.26266513 |
| 158 | cellular response to interferon-gamma (GO:0071346) | 2.21930629 |
| 159 | lymphocyte apoptotic process (GO:0070227) | 2.21407799 |
| 160 | response to protozoan (GO:0001562) | 2.20916927 |
| 161 | detection of molecule of bacterial origin (GO:0032490) | 2.20878861 |
| 162 | ribosomal small subunit biogenesis (GO:0042274) | 2.20403504 |
| 163 | B cell mediated immunity (GO:0019724) | 2.19978804 |
| 164 | positive regulation of T cell apoptotic process (GO:0070234) | 2.19210310 |
| 165 | angiogenesis involved in wound healing (GO:0060055) | 2.19013177 |
| 166 | maturation of SSU-rRNA (GO:0030490) | 2.18304076 |
| 167 | viral transcription (GO:0019083) | 2.17811822 |
| 168 | dendritic cell differentiation (GO:0097028) | 2.16539432 |
| 169 | lipopolysaccharide biosynthetic process (GO:0009103) | 2.16369965 |
| 170 | regulation of interleukin-8 biosynthetic process (GO:0045414) | 2.15778111 |
| 171 | macrophage activation involved in immune response (GO:0002281) | 2.15674102 |
| 172 | T-helper 1 type immune response (GO:0042088) | 2.14483230 |
| 173 | positive regulation of protein oligomerization (GO:0032461) | 2.14310207 |
| 174 | folic acid transport (GO:0015884) | 2.13188251 |
| 175 | regulation of antigen processing and presentation of peptide antigen (GO:0002583) | 2.12849966 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 5.55383290 |
| 2 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 4.00595149 |
| 3 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 3.61204716 |
| 4 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 3.21462740 |
| 5 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 3.10199261 |
| 6 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 2.93470528 |
| 7 | STAT6_21828071_ChIP-Seq_BEAS2B_Human | 2.85794436 |
| 8 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 2.84138925 |
| 9 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 2.48241400 |
| 10 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 2.39804448 |
| 11 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 2.23425369 |
| 12 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 2.22555030 |
| 13 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 2.20524999 |
| 14 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 2.14729844 |
| 15 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 2.13152936 |
| 16 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 2.11679026 |
| 17 | * MYB_21317192_ChIP-Seq_ERMYB_Mouse | 2.11122194 |
| 18 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 2.09025849 |
| 19 | NOTCH1_17114293_ChIP-ChIP_T-ALL_Human | 1.99164258 |
| 20 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 1.98076020 |
| 21 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.94411397 |
| 22 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 1.93109356 |
| 23 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 1.92286423 |
| 24 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 1.89044687 |
| 25 | * MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 1.88981823 |
| 26 | NOTCH1_21737748_ChIP-Seq_TLL_Human | 1.76830038 |
| 27 | SMAD4_19686287_ChIP-ChIP_HaCaT_Human | 1.73130164 |
| 28 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 1.72619666 |
| 29 | ATF3_23680149_ChIP-Seq_GBM1-GSC_Human | 1.71786323 |
| 30 | SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 1.67215073 |
| 31 | FOXM1_23109430_ChIP-Seq_U2OS_Human | 1.67141619 |
| 32 | * ELK3_25401928_ChIP-Seq_HUVEC_Human | 1.66477284 |
| 33 | SPI1_23547873_ChIP-Seq_NB4_Human | 1.64987351 |
| 34 | GATA1_22025678_ChIP-Seq_K562_Human | 1.63460154 |
| 35 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 1.57470258 |
| 36 | ASXL1_24218140_ChIP-Seq_BMDM_Mouse | 1.57465396 |
| 37 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 1.56754178 |
| 38 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 1.56668651 |
| 39 | TFEB_21752829_ChIP-Seq_HELA_Human | 1.56256192 |
| 40 | MAF_26560356_Chip-Seq_TH1_Human | 1.55773750 |
| 41 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.52163824 |
| 42 | * TAL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.51113457 |
| 43 | SMAD3_18955504_ChIP-ChIP_HaCaT_Human | 1.49753581 |
| 44 | SMAD2_18955504_ChIP-ChIP_HaCaT_Human | 1.49753581 |
| 45 | CIITA_18437201_ChIP-ChIP_Raji_B_and_iDC_Human | 1.49097852 |
| 46 | VDR_24787735_ChIP-Seq_THP-1_Human | 1.48365823 |
| 47 | * NELFA_20434984_ChIP-Seq_ESCs_Mouse | 1.47314702 |
| 48 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 1.45787348 |
| 49 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 1.45143811 |
| 50 | HIF1A_21447827_ChIP-Seq_MCF-7_Human | 1.44210689 |
| 51 | * FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.43383971 |
| 52 | VDR_24763502_ChIP-Seq_THP-1_Human | 1.41444642 |
| 53 | CHD7_19251738_ChIP-ChIP_MESCs_Mouse | 1.40550187 |
| 54 | CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 1.40140472 |
| 55 | JARID1A_20064375_ChIP-Seq_MESCs_Mouse | 1.39429576 |
| 56 | VDR_21846776_ChIP-Seq_THP-1_Human | 1.38120710 |
| 57 | HSF1_23293686_ChIP-Seq_STHDH_STRIATAL_Mouse | 1.37346288 |
| 58 | STAT3_1855785_ChIP-Seq_MESCs_Mouse | 1.36558807 |
| 59 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 1.33497355 |
| 60 | GABP_17652178_ChIP-ChIP_JURKAT_Human | 1.33018636 |
| 61 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 1.32869496 |
| 62 | * TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.32814346 |
| 63 | ZNF263_19887448_ChIP-Seq_K562_Human | 1.30937997 |
| 64 | MYB_26560356_Chip-Seq_TH1_Human | 1.30844431 |
| 65 | CLOCK_20551151_ChIP-Seq_293T_Human | 1.30814037 |
| 66 | E2F7_22180533_ChIP-Seq_HELA_Human | 1.30603245 |
| 67 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 1.30529366 |
| 68 | * MYB_26560356_Chip-Seq_TH2_Human | 1.27228734 |
| 69 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 1.26924015 |
| 70 | PU.1_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.23139578 |
| 71 | * RUNX2_24764292_ChIP-Seq_MC3T3_Mouse | 1.22234123 |
| 72 | * STAT1_20625510_ChIP-Seq_HELA_Human | 1.21606962 |
| 73 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 1.21408492 |
| 74 | FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 1.20126446 |
| 75 | SPI1_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.17716666 |
| 76 | TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.17707212 |
| 77 | BCL6_27268052_Chip-Seq_Bcells_Human | 1.16951991 |
| 78 | SCL_19346495_ChIP-Seq_HPC-7_Human | 1.16687432 |
| 79 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.16087816 |
| 80 | * FOXM1_25889361_ChIP-Seq_OE33_AND_U2OS_Human | 1.15318701 |
| 81 | XRN2_22483619_ChIP-Seq_HELA_Human | 1.15239404 |
| 82 | UTX_26944678_Chip-Seq_JUKART_Human | 1.14565665 |
| 83 | ELF1_17652178_ChIP-ChIP_JURKAT_Human | 1.14415070 |
| 84 | CEBPB_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.13326515 |
| 85 | CEBPB_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.13064168 |
| 86 | * SOX2_20726797_ChIP-Seq_SW620_Human | 1.12917083 |
| 87 | KLF5_18264089_ChIP-ChIP_MESCs_Mouse | 1.12748260 |
| 88 | KLF4_18264089_ChIP-ChIP_MESCs_Mouse | 1.12748260 |
| 89 | KLF2_18264089_ChIP-ChIP_MESCs_Mouse | 1.12748260 |
| 90 | * ELK1_22589737_ChIP-Seq_MCF10A_Human | 1.12159530 |
| 91 | LXR_22292898_ChIP-Seq_THP-1_Human | 1.11760362 |
| 92 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 1.09370592 |
| 93 | * BCOR_27268052_Chip-Seq_Bcells_Human | 1.08900617 |
| 94 | RUNX_20019798_ChIP-Seq_JUKART_Human | 1.08492911 |
| 95 | * CEBPB_24764292_ChIP-Seq_MC3T3_Mouse | 1.08435441 |
| 96 | KDM6A_18722178_ChIP-ChIP_U937_AND_SAOS2_Human | 1.07538094 |
| 97 | * TCF7_22412390_ChIP-Seq_EML_Mouse | 1.07319009 |
| 98 | MYC_22102868_ChIP-Seq_BL_Human | 1.07282000 |
| 99 | LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 1.06681281 |
| 100 | ATF3_27146783_Chip-Seq_COLON_Human | 1.06182397 |
| 101 | * JUND_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.05303667 |
| 102 | * ELF1_20517297_ChIP-Seq_JURKAT_Human | 1.04262872 |
| 103 | MAF_26560356_Chip-Seq_TH2_Human | 1.03598161 |
| 104 | UBF1/2_26484160_Chip-Seq_HMECs_Human | 1.03352614 |
| 105 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 1.03246542 |
| 106 | CEBPA_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.03104853 |
| 107 | PPARG_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.02439552 |
| 108 | SMARCA4_20176728_ChIP-ChIP_TSCs_Mouse | 0.98671933 |
| 109 | CEBPB_21427703_ChIP-Seq_3T3-L1_Mouse | 0.98154538 |
| 110 | TCF21_23034159_ChIP-ChIP_E13_GONADS_Rat | 0.97839750 |
| 111 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 0.97677559 |
| 112 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 0.97109412 |
| 113 | RACK7_27058665_Chip-Seq_MCF-7_Human | 0.96732188 |
| 114 | ETS1_20019798_ChIP-Seq_JURKAT_Human | 0.96532823 |
| 115 | KLF4_18358816_ChIP-ChIP_MESCs_Mouse | 0.96279712 |
| 116 | CEBPB_20176806_ChIP-Seq_MACROPHAGES_Mouse | 0.96251383 |
| 117 | DACH1_20351289_ChIP-Seq_MDA-MB-231_Human | 0.95986093 |
| 118 | PU.1_20176806_ChIP-Seq_MACROPHAGES_Mouse | 0.95850840 |
| 119 | SFPI1_20887958_ChIP-Seq_HPC-7_Mouse | 0.95346197 |
| 120 | P63_26484246_Chip-Seq_KERATINOCYTES_Human | 0.95311990 |
| 121 | KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 0.94320121 |
| 122 | * KDM2B_26808549_Chip-Seq_SUP-B15_Human | 0.93468670 |
| 123 | KLF6_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.93263184 |
| 124 | NFE2L2_22581777_ChIP-Seq_LYMPHOBLASTOID_Human | 0.92936722 |
| 125 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 0.92281016 |
| 126 | DCP1A_22483619_ChIP-Seq_HELA_Human | 0.92251642 |
| 127 | * NCOR1_26117541_ChIP-Seq_K562_Human | 0.91935488 |
| 128 | SPI1_23127762_ChIP-Seq_K562_Human | 0.91501532 |
| 129 | * TP53_22127205_ChIP-Seq_IMR90_Human | 0.90786863 |
| 130 | MYC_18555785_ChIP-Seq_MESCs_Mouse | 0.90540680 |
| 131 | * CEBPD_21427703_ChIP-Seq_3T3-L1_Mouse | 0.89059647 |
| 132 | GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 0.88692262 |
| 133 | JUN_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 0.87775235 |
| 134 | FOXA1_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.87348613 |
| 135 | CTCF_26484167_Chip-Seq_Bcells_Mouse | 0.85798476 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0009840_abnormal_foam_cell | 4.12488971 |
| 2 | MP0005058_abnormal_lysosome_morphology | 3.95853968 |
| 3 | MP0003724_increased_susceptibility_to | 3.44600866 |
| 4 | MP0003806_abnormal_nucleotide_metabolis | 2.70406472 |
| 5 | MP0009785_altered_susceptibility_to | 2.66558838 |
| 6 | MP0001835_abnormal_antigen_presentation | 2.54653414 |
| 7 | MP0003436_decreased_susceptibility_to | 2.51681830 |
| 8 | MP0000685_abnormal_immune_system | 2.48312785 |
| 9 | MP0003828_pulmonary_edema | 2.17998222 |
| 10 | MP0003075_altered_response_to | 2.16781059 |
| 11 | MP0006082_CNS_inflammation | 2.16260151 |
| 12 | MP0002148_abnormal_hypersensitivity_rea | 2.13634491 |
| 13 | MP0003303_peritoneal_inflammation | 2.09250689 |
| 14 | MP0002139_abnormal_hepatobiliary_system | 2.06804368 |
| 15 | MP0005000_abnormal_immune_tolerance | 2.06190252 |
| 16 | MP0005387_immune_system_phenotype | 1.93683657 |
| 17 | MP0001790_abnormal_immune_system | 1.93683657 |
| 18 | MP0009278_abnormal_bone_marrow | 1.88364618 |
| 19 | MP0001800_abnormal_humoral_immune | 1.83717781 |
| 20 | MP0002452_abnormal_antigen_presenting | 1.83535871 |
| 21 | MP0004947_skin_inflammation | 1.79094605 |
| 22 | MP0005025_abnormal_response_to | 1.79046791 |
| 23 | MP0003279_aneurysm | 1.79024302 |
| 24 | MP0001545_abnormal_hematopoietic_system | 1.74827369 |
| 25 | MP0005397_hematopoietic_system_phenotyp | 1.74827369 |
| 26 | MP0002723_abnormal_immune_serum | 1.73110600 |
| 27 | MP0005671_abnormal_response_to | 1.73007018 |
| 28 | MP0003941_abnormal_skin_development | 1.71568405 |
| 29 | MP0002419_abnormal_innate_immunity | 1.71514681 |
| 30 | MP0010155_abnormal_intestine_physiology | 1.70010182 |
| 31 | MP0001533_abnormal_skeleton_physiology | 1.68777731 |
| 32 | MP0009333_abnormal_splenocyte_physiolog | 1.68154558 |
| 33 | MP0003763_abnormal_thymus_physiology | 1.64471587 |
| 34 | MP0002405_respiratory_system_inflammati | 1.62684372 |
| 35 | MP0003448_altered_tumor_morphology | 1.62024444 |
| 36 | MP0002138_abnormal_hepatobiliary_system | 1.61042516 |
| 37 | MP0001853_heart_inflammation | 1.59912243 |
| 38 | MP0000604_amyloidosis | 1.59198526 |
| 39 | MP0003453_abnormal_keratinocyte_physiol | 1.58344057 |
| 40 | MP0002420_abnormal_adaptive_immunity | 1.56875563 |
| 41 | MP0001819_abnormal_immune_cell | 1.56624774 |
| 42 | MP0010234_abnormal_vibrissa_follicle | 1.56491561 |
| 43 | MP0001873_stomach_inflammation | 1.55500618 |
| 44 | MP0000858_altered_metastatic_potential | 1.54460096 |
| 45 | MP0008438_abnormal_cutaneous_collagen | 1.54378668 |
| 46 | MP0005023_abnormal_wound_healing | 1.52376316 |
| 47 | MP0000465_gastrointestinal_hemorrhage | 1.51411907 |
| 48 | MP0005451_abnormal_body_composition | 1.49608377 |
| 49 | MP0008007_abnormal_cellular_replicative | 1.45553444 |
| 50 | MP0002166_altered_tumor_susceptibility | 1.43962919 |
| 51 | MP0005275_abnormal_skin_tensile | 1.43371592 |
| 52 | MP0004808_abnormal_hematopoietic_stem | 1.43290395 |
| 53 | MP0002332_abnormal_exercise_endurance | 1.42161553 |
| 54 | MP0010352_gastrointestinal_tract_polyps | 1.39212104 |
| 55 | MP0000750_abnormal_muscle_regeneration | 1.39112234 |
| 56 | MP0010368_abnormal_lymphatic_system | 1.38480690 |
| 57 | MP0004510_myositis | 1.38039319 |
| 58 | MP0002254_reproductive_system_inflammat | 1.37202268 |
| 59 | MP0003172_abnormal_lysosome_physiology | 1.35147617 |
| 60 | MP0005390_skeleton_phenotype | 1.35109262 |
| 61 | MP0002877_abnormal_melanocyte_morpholog | 1.34717287 |
| 62 | MP0002006_tumorigenesis | 1.33315039 |
| 63 | MP0002009_preneoplasia | 1.32920243 |
| 64 | MP0003195_calcinosis | 1.32616909 |
| 65 | MP0002398_abnormal_bone_marrow | 1.32216740 |
| 66 | MP0002132_abnormal_respiratory_system | 1.30869696 |
| 67 | MP0002060_abnormal_skin_morphology | 1.28111633 |
| 68 | MP0001845_abnormal_inflammatory_respons | 1.27302123 |
| 69 | MP0003705_abnormal_hypodermis_morpholog | 1.27080089 |
| 70 | MP0003950_abnormal_plasma_membrane | 1.26313663 |
| 71 | MP0003191_abnormal_cellular_cholesterol | 1.26311340 |
| 72 | MP0005464_abnormal_platelet_physiology | 1.25709967 |
| 73 | MP0005165_increased_susceptibility_to | 1.25392408 |
| 74 | MP0000716_abnormal_immune_system | 1.22721886 |
| 75 | MP0000767_abnormal_smooth_muscle | 1.22433194 |
| 76 | MP0005164_abnormal_response_to | 1.21258974 |
| 77 | MP0005310_abnormal_salivary_gland | 1.20812030 |
| 78 | MP0002933_joint_inflammation | 1.20494930 |
| 79 | MP0002722_abnormal_immune_system | 1.19881452 |
| 80 | MP0001542_abnormal_bone_strength | 1.19610551 |
| 81 | MP0001851_eye_inflammation | 1.19604809 |
| 82 | MP0008004_abnormal_stomach_pH | 1.19591618 |
| 83 | MP0004883_abnormal_blood_vessel | 1.18877797 |
| 84 | MP0009379_abnormal_foot_pigmentation | 1.18485081 |
| 85 | MP0003091_abnormal_cell_migration | 1.17759777 |
| 86 | MP0005076_abnormal_cell_differentiation | 1.17605696 |
| 87 | MP0000343_altered_response_to | 1.16852236 |
| 88 | MP0003566_abnormal_cell_adhesion | 1.15891674 |
| 89 | MP0002396_abnormal_hematopoietic_system | 1.15534468 |
| 90 | MP0009764_decreased_sensitivity_to | 1.14472782 |
| 91 | MP0010307_abnormal_tumor_latency | 1.14348932 |
| 92 | MP0000490_abnormal_crypts_of | 1.11866816 |
| 93 | MP0000689_abnormal_spleen_morphology | 1.09055179 |
| 94 | MP0002429_abnormal_blood_cell | 1.08528361 |
| 95 | MP0005167_abnormal_blood-brain_barrier | 1.06312949 |
| 96 | MP0006054_spinal_hemorrhage | 1.05770577 |
| 97 | MP0004782_abnormal_surfactant_physiolog | 1.03284025 |
| 98 | MP0002837_dystrophic_cardiac_calcinosis | 1.02282604 |
| 99 | MP0003693_abnormal_embryo_hatching | 1.01439558 |
| 100 | MP0001879_abnormal_lymphatic_vessel | 0.99453562 |
| 101 | MP0008469_abnormal_protein_level | 0.97675446 |
| 102 | MP0000249_abnormal_blood_vessel | 0.95276279 |
| 103 | MP0003866_abnormal_defecation | 0.95141933 |
| 104 | MP0003300_gastrointestinal_ulcer | 0.94797267 |
| 105 | MP0002277_abnormal_respiratory_mucosa | 0.94712241 |
| 106 | MP0005508_abnormal_skeleton_morphology | 0.94046596 |
| 107 | MP0009384_cardiac_valve_regurgitation | 0.93867017 |
| 108 | MP0003646_muscle_fatigue | 0.93831343 |
| 109 | MP0001216_abnormal_epidermal_layer | 0.93644447 |
| 110 | MP0003943_abnormal_hepatobiliary_system | 0.90829238 |
| 111 | MP0005166_decreased_susceptibility_to | 0.90319421 |
| 112 | MP0008875_abnormal_xenobiotic_pharmacok | 0.89922748 |
| 113 | MP0000703_abnormal_thymus_morphology | 0.89398692 |
| 114 | MP0005595_abnormal_vascular_smooth | 0.89373841 |
| 115 | MP0005367_renal/urinary_system_phenotyp | 0.88786485 |
| 116 | MP0000516_abnormal_urinary_system | 0.88786485 |
| 117 | MP0002796_impaired_skin_barrier | 0.88110872 |
| 118 | MP0002998_abnormal_bone_remodeling | 0.83951966 |
| 119 | MP0010030_abnormal_orbit_morphology | 0.83346269 |
| 120 | MP0003186_abnormal_redox_activity | 0.83155941 |
| 121 | MP0003656_abnormal_erythrocyte_physiolo | 0.83006188 |
| 122 | MP0003795_abnormal_bone_structure | 0.82552603 |
| 123 | MP0001191_abnormal_skin_condition | 0.79361604 |
| 124 | MP0008260_abnormal_autophagy | 0.77788775 |
| 125 | MP0009763_increased_sensitivity_to | 0.75787951 |
| 126 | MP0001764_abnormal_homeostasis | 0.73822113 |
| 127 | MP0001243_abnormal_dermal_layer | 0.71772529 |
| 128 | MP0001663_abnormal_digestive_system | 0.71100781 |
| 129 | MP0005647_abnormal_sex_gland | 0.70287957 |
| 130 | MP0001727_abnormal_embryo_implantation | 0.69487860 |
| 131 | MP0003221_abnormal_cardiomyocyte_apopto | 0.69054191 |
| 132 | MP0005319_abnormal_enzyme/_coenzyme | 0.67937339 |
| 133 | MP0003329_amyloid_beta_deposits | 0.64442283 |
| 134 | MP0002136_abnormal_kidney_physiology | 0.63012100 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Abnormality of liposaccharide metabolism (HP:0010968) | 7.38663991 |
| 2 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 7.38663991 |
| 3 | Abnormality of glycolipid metabolism (HP:0010969) | 7.38663991 |
| 4 | Increased cerebral lipofuscin (HP:0011813) | 4.49743735 |
| 5 | Dysostosis multiplex (HP:0000943) | 4.30661240 |
| 6 | Eczematoid dermatitis (HP:0000976) | 4.00503289 |
| 7 | Increased neuronal autofluorescent lipopigment (HP:0002074) | 3.94571182 |
| 8 | Loss of speech (HP:0002371) | 3.91651815 |
| 9 | Mutism (HP:0002300) | 3.78103375 |
| 10 | Myositis (HP:0100614) | 3.72473614 |
| 11 | Orchitis (HP:0100796) | 3.72016479 |
| 12 | Disinhibition (HP:0000734) | 3.66999756 |
| 13 | Recurrent abscess formation (HP:0002722) | 3.60669283 |
| 14 | Anomalous pulmonary venous return (HP:0010772) | 3.51466660 |
| 15 | Abnormality of mucopolysaccharide metabolism (HP:0011020) | 3.49691489 |
| 16 | Abnormality of polysaccharide metabolism (HP:0011012) | 3.49691489 |
| 17 | Abnormality of glycosaminoglycan metabolism (HP:0004371) | 3.49691489 |
| 18 | Elevated erythrocyte sedimentation rate (HP:0003565) | 3.41849161 |
| 19 | Nuclear cataract (HP:0100018) | 3.31760572 |
| 20 | Abnormality of the pulmonary veins (HP:0011718) | 3.30410575 |
| 21 | Recurrent bacterial skin infections (HP:0005406) | 3.29008908 |
| 22 | Pustule (HP:0200039) | 3.25108027 |
| 23 | Optic neuritis (HP:0100653) | 3.20817187 |
| 24 | Retrobulbar optic neuritis (HP:0100654) | 3.20817187 |
| 25 | Urinary glycosaminoglycan excretion (HP:0003541) | 3.11638296 |
| 26 | Mucopolysacchariduria (HP:0008155) | 3.11638296 |
| 27 | Increased serum ferritin (HP:0003281) | 3.02431881 |
| 28 | Parakeratosis (HP:0001036) | 2.98867342 |
| 29 | Hematochezia (HP:0002573) | 2.92499770 |
| 30 | Premature rupture of membranes (HP:0001788) | 2.81877058 |
| 31 | Nonimmune hydrops fetalis (HP:0001790) | 2.74190591 |
| 32 | Congenital nonbullous ichthyosiform erythroderma (HP:0007479) | 2.71947862 |
| 33 | Osteolytic defects of the hand bones (HP:0009699) | 2.71813971 |
| 34 | Osteolytic defects of the phalanges of the hand (HP:0009771) | 2.71813971 |
| 35 | Prolonged neonatal jaundice (HP:0006579) | 2.70586098 |
| 36 | Progressive neurologic deterioration (HP:0002344) | 2.64836194 |
| 37 | Primitive reflexes (palmomental, snout, glabellar) (HP:0002476) | 2.62157730 |
| 38 | Prostate neoplasm (HP:0100787) | 2.61190802 |
| 39 | Autoimmune thrombocytopenia (HP:0001973) | 2.55686002 |
| 40 | Diaphragmatic weakness (HP:0009113) | 2.54248391 |
| 41 | Thick nail (HP:0001805) | 2.54038291 |
| 42 | Axonal loss (HP:0003447) | 2.50462090 |
| 43 | Abnormality of iron homeostasis (HP:0011031) | 2.48601533 |
| 44 | Protrusio acetabuli (HP:0003179) | 2.47724380 |
| 45 | Chronic otitis media (HP:0000389) | 2.42385563 |
| 46 | Neurofibrillary tangles (HP:0002185) | 2.40139553 |
| 47 | Nausea (HP:0002018) | 2.38745106 |
| 48 | Spontaneous hematomas (HP:0007420) | 2.38399423 |
| 49 | Glomerulonephritis (HP:0000099) | 2.36953665 |
| 50 | Abnormality of the nasal mucosa (HP:0000433) | 2.36568421 |
| 51 | Petechiae (HP:0000967) | 2.36353623 |
| 52 | Mediastinal lymphadenopathy (HP:0100721) | 2.35715538 |
| 53 | Increased IgM level (HP:0003496) | 2.35661786 |
| 54 | Polycythemia (HP:0001901) | 2.33340368 |
| 55 | Stomatitis (HP:0010280) | 2.31615956 |
| 56 | Amyloidosis (HP:0011034) | 2.31502129 |
| 57 | Thrombocytosis (HP:0001894) | 2.29736652 |
| 58 | Myocardial infarction (HP:0001658) | 2.29423250 |
| 59 | Metaphyseal irregularity (HP:0003025) | 2.28815428 |
| 60 | Malnutrition (HP:0004395) | 2.27283791 |
| 61 | Intracellular accumulation of autofluorescent lipopigment storage material (HP:0003204) | 2.27278809 |
| 62 | Vertebral compression fractures (HP:0002953) | 2.27101753 |
| 63 | Mesangial abnormality (HP:0001966) | 2.26227145 |
| 64 | Upper motor neuron abnormality (HP:0002127) | 2.25491888 |
| 65 | Arterial thrombosis (HP:0004420) | 2.24274095 |
| 66 | Abnormality of the odontoid process (HP:0003310) | 2.24223449 |
| 67 | Abnormality of macrophages (HP:0004311) | 2.23636317 |
| 68 | Apathy (HP:0000741) | 2.23318417 |
| 69 | Diminished motivation (HP:0000745) | 2.20655074 |
| 70 | Reticulocytopenia (HP:0001896) | 2.19787229 |
| 71 | Stomach cancer (HP:0012126) | 2.19558742 |
| 72 | Abnormality of transition element cation homeostasis (HP:0011030) | 2.18625925 |
| 73 | Interstitial pulmonary disease (HP:0006530) | 2.17223280 |
| 74 | Recurrent fungal infections (HP:0002841) | 2.16686254 |
| 75 | Abnormality of the vasculature of the conjunctiva (HP:0008054) | 2.16556642 |
| 76 | Vasculitis (HP:0002633) | 2.15017816 |
| 77 | Distal lower limb muscle weakness (HP:0009053) | 2.14020564 |
| 78 | Abnormality of the intervertebral disk (HP:0005108) | 2.13233266 |
| 79 | Systemic lupus erythematosus (HP:0002725) | 2.12176622 |
| 80 | Increased CSF protein (HP:0002922) | 2.11813006 |
| 81 | Congenital ichthyosiform erythroderma (HP:0007431) | 2.11294299 |
| 82 | Cellulitis (HP:0100658) | 2.08720646 |
| 83 | Cupped ribs (HP:0000887) | 2.05894747 |
| 84 | Congenital, generalized hypertrichosis (HP:0004540) | 2.04017621 |
| 85 | Decreased activity of cytochrome C oxidase in muscle tissue (HP:0003688) | 2.03468114 |
| 86 | Abnormality of lateral ventricle (HP:0030047) | 2.03306435 |
| 87 | Anhidrosis (HP:0000970) | 2.02740027 |
| 88 | Cardiomegaly (HP:0001640) | 2.02696831 |
| 89 | Polyneuropathy (HP:0001271) | 2.01463479 |
| 90 | Peritonitis (HP:0002586) | 2.00416052 |
| 91 | Leukocytosis (HP:0001974) | 2.00227905 |
| 92 | Vacuolated lymphocytes (HP:0001922) | 2.00092181 |
| 93 | Hepatosplenomegaly (HP:0001433) | 1.99434984 |
| 94 | Nasal polyposis (HP:0100582) | 1.98028109 |
| 95 | Impaired platelet aggregation (HP:0003540) | 1.97243424 |
| 96 | Abnormal platelet function (HP:0011869) | 1.97243424 |
| 97 | Alopecia of scalp (HP:0002293) | 1.95336976 |
| 98 | Fatigue (HP:0012378) | 1.94895758 |
| 99 | Aortic dissection (HP:0002647) | 1.94886981 |
| 100 | Inappropriate behavior (HP:0000719) | 1.94532810 |
| 101 | Keratoconjunctivitis sicca (HP:0001097) | 1.94287112 |
| 102 | Abnormality of the distal phalanges of the toes (HP:0010182) | 1.94107029 |
| 103 | Pulmonary infiltrates (HP:0002113) | 1.93713813 |
| 104 | Tetraparesis (HP:0002273) | 1.93368167 |
| 105 | Increased IgE level (HP:0003212) | 1.93124824 |
| 106 | Abnormal trabecular bone morphology (HP:0100671) | 1.92800853 |
| 107 | Purpura (HP:0000979) | 1.90876208 |
| 108 | Basal ganglia calcification (HP:0002135) | 1.90520833 |
| 109 | Albinism (HP:0001022) | 1.89344769 |
| 110 | Abnormal tarsal ossification (HP:0008369) | 1.88748615 |
| 111 | Recurrent skin infections (HP:0001581) | 1.87360304 |
| 112 | Milia (HP:0001056) | 1.85809522 |
| 113 | Onycholysis (HP:0001806) | 1.84796759 |
| 114 | Aortic aneurysm (HP:0004942) | 1.84708670 |
| 115 | Eosinophilia (HP:0001880) | 1.84631859 |
| 116 | Breast hypoplasia (HP:0003187) | 1.84319787 |
| 117 | Autoimmune hemolytic anemia (HP:0001890) | 1.83102167 |
| 118 | Neuronal loss in central nervous system (HP:0002529) | 1.82512100 |
| 119 | Segmental peripheral demyelination/remyelination (HP:0003481) | 1.82354994 |
| 120 | Plantar hyperkeratosis (HP:0007556) | 1.81750987 |
| 121 | Hypoproteinemia (HP:0003075) | 1.81623439 |
| 122 | Recurrent viral infections (HP:0004429) | 1.81401812 |
| 123 | Bone cyst (HP:0012062) | 1.81327378 |
| 124 | Abnormality of cells of the erythroid lineage (HP:0012130) | 1.80938499 |
| 125 | Hypergammaglobulinemia (HP:0010702) | 1.80439417 |
| 126 | Atrophic scars (HP:0001075) | 1.79700243 |
| 127 | Abnormal isoelectric focusing of serum transferrin (HP:0003160) | 1.79580892 |
| 128 | Abnormal protein N-linked glycosylation (HP:0012347) | 1.79580892 |
| 129 | Abnormal protein glycosylation (HP:0012346) | 1.79580892 |
| 130 | Abnormal glycosylation (HP:0012345) | 1.79580892 |
| 131 | Skin ulcer (HP:0200042) | 1.78839871 |
| 132 | Short nail (HP:0001799) | 1.78133248 |
| 133 | Increased connective tissue (HP:0009025) | 1.77645686 |
| 134 | Dementia (HP:0000726) | 1.77387756 |
| 135 | Keratoconjunctivitis (HP:0001096) | 1.77202179 |
| 136 | Periodontitis (HP:0000704) | 1.76817713 |
| 137 | Fragile nails (HP:0001808) | 1.75318009 |
| 138 | Alveolar cell carcinoma (HP:0006519) | 1.74135786 |
| 139 | Poor head control (HP:0002421) | 1.70948159 |
| 140 | Micronodular cirrhosis (HP:0001413) | 1.70728408 |
| 141 | Obstructive lung disease (HP:0006536) | 1.68859061 |
| 142 | Chronic obstructive pulmonary disease (HP:0006510) | 1.68859061 |
| 143 | Asymmetric septal hypertrophy (HP:0001670) | 1.68812930 |
| 144 | Hemoptysis (HP:0002105) | 1.68764691 |
| 145 | J-shaped sella turcica (HP:0002680) | 1.66643339 |
| 146 | Recurrent gram-negative bacterial infections (HP:0005420) | 1.66639067 |
| 147 | Tubular atrophy (HP:0000092) | 1.66493946 |
| 148 | Recurrent pneumonia (HP:0006532) | 1.66407897 |
| 149 | Muscle abnormality related to mitochondrial dysfunction (HP:0003800) | 1.66031754 |
| 150 | Reduced subcutaneous adipose tissue (HP:0003758) | 1.65982092 |
| 151 | Hypertensive crisis (HP:0100735) | 1.65788204 |
| 152 | Retinal atrophy (HP:0001105) | 1.65666485 |
| 153 | Abnormal foot bone ossification (HP:0010675) | 1.64899957 |
| 154 | Gangrene (HP:0100758) | 1.64868406 |
| 155 | Abnormal number of erythroid precursors (HP:0012131) | 1.64141300 |
| 156 | Esophageal varix (HP:0002040) | 1.63612209 |
| 157 | Rough bone trabeculation (HP:0100670) | 1.63221701 |
| 158 | Abnormality of the pericardium (HP:0001697) | 1.62830633 |
| 159 | Abnormality of eosinophils (HP:0001879) | 1.62016768 |
| 160 | Entropion (HP:0000621) | 1.61668507 |
| 161 | Joint stiffness (HP:0001387) | 1.59801031 |
| 162 | Personality changes (HP:0000751) | 1.58388958 |
| 163 | Upper limb muscle weakness (HP:0003484) | 1.57857398 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | PIM2 | 3.43332367 |
| 2 | MAP3K14 | 2.96787217 |
| 3 | IRAK3 | 2.78534097 |
| 4 | CDK12 | 2.69470154 |
| 5 | MAP3K3 | 2.57211091 |
| 6 | NME2 | 2.46403478 |
| 7 | TYK2 | 2.43452158 |
| 8 | MAP3K12 | 2.24640650 |
| 9 | IKBKB | 2.17519261 |
| 10 | TBK1 | 2.17275142 |
| 11 | KDR | 1.92544964 |
| 12 | TGFBR2 | 1.92536787 |
| 13 | ADRBK2 | 1.89933740 |
| 14 | MAP4K1 | 1.89446247 |
| 15 | IKBKE | 1.86374390 |
| 16 | STK10 | 1.83592317 |
| 17 | MAP2K2 | 1.80584826 |
| 18 | ERN1 | 1.75842209 |
| 19 | ZAK | 1.73761107 |
| 20 | MAP2K3 | 1.72502598 |
| 21 | JAK3 | 1.71327950 |
| 22 | PIM1 | 1.70606604 |
| 23 | TIE1 | 1.68776021 |
| 24 | RPS6KA4 | 1.60523337 |
| 25 | EPHA2 | 1.59470929 |
| 26 | PBK | 1.54541717 |
| 27 | TEC | 1.54504209 |
| 28 | MAP3K11 | 1.51323656 |
| 29 | DDR2 | 1.46089811 |
| 30 | ZAP70 | 1.45790475 |
| 31 | CHUK | 1.37533665 |
| 32 | NLK | 1.36771340 |
| 33 | TXK | 1.34857056 |
| 34 | LIMK1 | 1.31979586 |
| 35 | IRAK4 | 1.30678193 |
| 36 | BRD4 | 1.24581161 |
| 37 | VRK1 | 1.19475755 |
| 38 | STK4 | 1.18978490 |
| 39 | TAOK1 | 1.18304646 |
| 40 | CDK9 | 1.16220680 |
| 41 | PRPF4B | 1.15270886 |
| 42 | TAOK3 | 1.14185691 |
| 43 | TESK1 | 1.11179548 |
| 44 | MATK | 1.11003032 |
| 45 | KIT | 1.10302055 |
| 46 | STK24 | 1.09261498 |
| 47 | MST4 | 1.09212537 |
| 48 | MARK3 | 1.08284554 |
| 49 | IRAK1 | 1.03927960 |
| 50 | EPHB1 | 1.03076990 |
| 51 | BCKDK | 1.02745983 |
| 52 | BLK | 1.01097059 |
| 53 | BTK | 0.99414631 |
| 54 | EPHA3 | 0.99122289 |
| 55 | CDK8 | 0.98776516 |
| 56 | PRKG2 | 0.98221819 |
| 57 | STK16 | 0.97693546 |
| 58 | JAK1 | 0.97286848 |
| 59 | ITK | 0.96541627 |
| 60 | MAP3K1 | 0.95558143 |
| 61 | MAPK15 | 0.95191205 |
| 62 | PAK4 | 0.94961518 |
| 63 | TESK2 | 0.94553621 |
| 64 | DYRK3 | 0.94521739 |
| 65 | ACVR1B | 0.90385434 |
| 66 | ARAF | 0.89849477 |
| 67 | TLK1 | 0.88925874 |
| 68 | CAMKK2 | 0.88036666 |
| 69 | CDK6 | 0.87316979 |
| 70 | ABL2 | 0.87274133 |
| 71 | HIPK2 | 0.84981345 |
| 72 | MAPKAPK2 | 0.84754465 |
| 73 | RPS6KB2 | 0.84438412 |
| 74 | TGFBR1 | 0.82252444 |
| 75 | RPS6KA5 | 0.80872077 |
| 76 | TAOK2 | 0.80590347 |
| 77 | MOS | 0.79582572 |
| 78 | NEK9 | 0.78161743 |
| 79 | MYLK | 0.77841735 |
| 80 | HCK | 0.77266498 |
| 81 | LATS2 | 0.73598179 |
| 82 | EIF2AK2 | 0.72824784 |
| 83 | TRPM7 | 0.71425796 |
| 84 | CSK | 0.71180865 |
| 85 | SIK3 | 0.68024448 |
| 86 | BMPR2 | 0.67977824 |
| 87 | STK3 | 0.67502289 |
| 88 | RPS6KA6 | 0.66020099 |
| 89 | MAP3K5 | 0.64752123 |
| 90 | PRKD2 | 0.64574521 |
| 91 | MST1R | 0.64169990 |
| 92 | GSK3A | 0.64019981 |
| 93 | EIF2AK3 | 0.63728726 |
| 94 | FGR | 0.62593212 |
| 95 | LRRK2 | 0.62522029 |
| 96 | RIPK1 | 0.59918631 |
| 97 | EPHB2 | 0.58822312 |
| 98 | PDK2 | 0.58422875 |
| 99 | MAP2K6 | 0.57863882 |
| 100 | FGFR4 | 0.57550984 |
| 101 | MAPKAPK3 | 0.57028193 |
| 102 | MELK | 0.55879201 |
| 103 | CDC42BPA | 0.53593826 |
| 104 | LCK | 0.52636430 |
| 105 | NEK2 | 0.51911955 |
| 106 | IRAK2 | 0.51011441 |
| 107 | GRK7 | 0.50989183 |
| 108 | RPS6KC1 | 0.50564759 |
| 109 | RPS6KL1 | 0.50564759 |
| 110 | STK38L | 0.50078378 |
| 111 | CDK7 | 0.49272869 |
| 112 | ADRBK1 | 0.48861861 |
| 113 | MAP3K8 | 0.48562221 |
| 114 | AURKB | 0.45182971 |
| 115 | ABL1 | 0.44416714 |
| 116 | WEE1 | 0.43928226 |
| 117 | BRSK2 | 0.42927792 |
| 118 | DAPK3 | 0.42782323 |
| 119 | JAK2 | 0.40331875 |
| 120 | PRKCI | 0.39453253 |
| 121 | GRK1 | 0.39365051 |
| 122 | MAPK7 | 0.38851265 |
| 123 | CDK4 | 0.38848470 |
| 124 | LYN | 0.38334310 |
| 125 | PIK3CA | 0.36999899 |
| 126 | MAP3K10 | 0.36011002 |
| 127 | PAK1 | 0.34317558 |
| 128 | CSF1R | 0.33268938 |
| 129 | DMPK | 0.32485793 |
| 130 | MAPK4 | 0.31241678 |
| 131 | PKN1 | 0.30342770 |
| 132 | PRKCD | 0.30287461 |
| 133 | ERBB4 | 0.27518514 |
| 134 | ILK | 0.27413310 |
| 135 | BUB1 | 0.26782827 |
| 136 | CAMK2G | 0.26554447 |
| 137 | RPS6KA1 | 0.25171570 |
| 138 | BMX | 0.24367182 |
| 139 | INSR | 0.17316116 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 2.68650324 |
| 2 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 2.63456343 |
| 3 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 2.53495492 |
| 4 | Leishmaniasis_Homo sapiens_hsa05140 | 2.51185009 |
| 5 | Malaria_Homo sapiens_hsa05144 | 2.13026242 |
| 6 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 2.02027052 |
| 7 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 2.01462301 |
| 8 | Herpes simplex infection_Homo sapiens_hsa05168 | 1.89635475 |
| 9 | Ribosome_Homo sapiens_hsa03010 | 1.89557657 |
| 10 | RNA polymerase_Homo sapiens_hsa03020 | 1.87246514 |
| 11 | Measles_Homo sapiens_hsa05162 | 1.86471160 |
| 12 | TNF signaling pathway_Homo sapiens_hsa04668 | 1.85937236 |
| 13 | Legionellosis_Homo sapiens_hsa05134 | 1.85468177 |
| 14 | Graft-versus-host disease_Homo sapiens_hsa05332 | 1.83629218 |
| 15 | Pertussis_Homo sapiens_hsa05133 | 1.79293697 |
| 16 | Osteoclast differentiation_Homo sapiens_hsa04380 | 1.76339852 |
| 17 | Apoptosis_Homo sapiens_hsa04210 | 1.74629997 |
| 18 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 1.73340921 |
| 19 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 1.65794465 |
| 20 | Toxoplasmosis_Homo sapiens_hsa05145 | 1.62577369 |
| 21 | Sulfur metabolism_Homo sapiens_hsa00920 | 1.62418968 |
| 22 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 1.61343005 |
| 23 | p53 signaling pathway_Homo sapiens_hsa04115 | 1.56613419 |
| 24 | Influenza A_Homo sapiens_hsa05164 | 1.55741673 |
| 25 | Allograft rejection_Homo sapiens_hsa05330 | 1.52170153 |
| 26 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 1.46909841 |
| 27 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 1.42773935 |
| 28 | Antigen processing and presentation_Homo sapiens_hsa04612 | 1.38356766 |
| 29 | Sulfur relay system_Homo sapiens_hsa04122 | 1.38272438 |
| 30 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 1.37226573 |
| 31 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 1.34287719 |
| 32 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 1.33692938 |
| 33 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 1.33344454 |
| 34 | Hepatitis B_Homo sapiens_hsa05161 | 1.32617503 |
| 35 | Primary immunodeficiency_Homo sapiens_hsa05340 | 1.30918464 |
| 36 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 1.30561122 |
| 37 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 1.25846174 |
| 38 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 1.24130598 |
| 39 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 1.22375402 |
| 40 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 1.21024970 |
| 41 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 1.17012878 |
| 42 | Shigellosis_Homo sapiens_hsa05131 | 1.15865531 |
| 43 | Prion diseases_Homo sapiens_hsa05020 | 1.13955104 |
| 44 | Salmonella infection_Homo sapiens_hsa05132 | 1.12846976 |
| 45 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 1.11381920 |
| 46 | Small cell lung cancer_Homo sapiens_hsa05222 | 1.09388876 |
| 47 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 1.08835109 |
| 48 | Tuberculosis_Homo sapiens_hsa05152 | 1.07921719 |
| 49 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 1.07709142 |
| 50 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 1.05017774 |
| 51 | Hepatitis C_Homo sapiens_hsa05160 | 1.03901512 |
| 52 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 1.03427704 |
| 53 | Folate biosynthesis_Homo sapiens_hsa00790 | 1.02854110 |
| 54 | Transcriptional misregulation in cancer_Homo sapiens_hsa05202 | 1.02397876 |
| 55 | Pyrimidine metabolism_Homo sapiens_hsa00240 | 1.02146948 |
| 56 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 1.02000307 |
| 57 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 0.98976382 |
| 58 | HTLV-I infection_Homo sapiens_hsa05166 | 0.98024812 |
| 59 | Other glycan degradation_Homo sapiens_hsa00511 | 0.97629224 |
| 60 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 0.97378072 |
| 61 | Bladder cancer_Homo sapiens_hsa05219 | 0.93028272 |
| 62 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.92589972 |
| 63 | Proteasome_Homo sapiens_hsa03050 | 0.91778385 |
| 64 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 0.91100092 |
| 65 | Asthma_Homo sapiens_hsa05310 | 0.90795536 |
| 66 | African trypanosomiasis_Homo sapiens_hsa05143 | 0.88290240 |
| 67 | Viral carcinogenesis_Homo sapiens_hsa05203 | 0.85506095 |
| 68 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 0.85469933 |
| 69 | ECM-receptor interaction_Homo sapiens_hsa04512 | 0.83447471 |
| 70 | Ribosome biogenesis in eukaryotes_Homo sapiens_hsa03008 | 0.82460431 |
| 71 | Cell cycle_Homo sapiens_hsa04110 | 0.82276481 |
| 72 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 0.82226672 |
| 73 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 0.79526679 |
| 74 | Viral myocarditis_Homo sapiens_hsa05416 | 0.78804725 |
| 75 | Basal transcription factors_Homo sapiens_hsa03022 | 0.76567139 |
| 76 | Amoebiasis_Homo sapiens_hsa05146 | 0.74838151 |
| 77 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 0.74033491 |
| 78 | Regulation of autophagy_Homo sapiens_hsa04140 | 0.72497607 |
| 79 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 0.71549924 |
| 80 | TGF-beta signaling pathway_Homo sapiens_hsa04350 | 0.69394907 |
| 81 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 0.68709426 |
| 82 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | 0.68684461 |
| 83 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.68586969 |
| 84 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 0.68319734 |
| 85 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 0.68191751 |
| 86 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 0.67964407 |
| 87 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 0.64339925 |
| 88 | Phagosome_Homo sapiens_hsa04145 | 0.63622897 |
| 89 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.62919832 |
| 90 | MicroRNAs in cancer_Homo sapiens_hsa05206 | 0.61622254 |
| 91 | Base excision repair_Homo sapiens_hsa03410 | 0.61526567 |
| 92 | Lysosome_Homo sapiens_hsa04142 | 0.58991571 |
| 93 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.58739242 |
| 94 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.58532773 |
| 95 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 0.54759080 |
| 96 | Mineral absorption_Homo sapiens_hsa04978 | 0.53970415 |
| 97 | Focal adhesion_Homo sapiens_hsa04510 | 0.52262521 |
| 98 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 0.51972248 |
| 99 | Platelet activation_Homo sapiens_hsa04611 | 0.51317448 |
| 100 | FoxO signaling pathway_Homo sapiens_hsa04068 | 0.50893456 |
| 101 | Glutathione metabolism_Homo sapiens_hsa00480 | 0.50565182 |
| 102 | Proteoglycans in cancer_Homo sapiens_hsa05205 | 0.49866180 |
| 103 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 0.48516398 |
| 104 | Pancreatic cancer_Homo sapiens_hsa05212 | 0.48369512 |
| 105 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 0.47847403 |
| 106 | Adherens junction_Homo sapiens_hsa04520 | 0.47537461 |
| 107 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 0.47386440 |
| 108 | Non-homologous end-joining_Homo sapiens_hsa03450 | 0.47182457 |
| 109 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.46249490 |
| 110 | DNA replication_Homo sapiens_hsa03030 | 0.45961211 |
| 111 | Galactose metabolism_Homo sapiens_hsa00052 | 0.43909044 |
| 112 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 0.43008969 |
| 113 | RNA degradation_Homo sapiens_hsa03018 | 0.42982450 |
| 114 | Pathways in cancer_Homo sapiens_hsa05200 | 0.41387604 |
| 115 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.40137823 |
| 116 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 0.39904026 |
| 117 | Glycosaminoglycan biosynthesis - heparan sulfate / heparin_Homo sapiens_hsa00534 | 0.39687366 |
| 118 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 0.39147995 |
| 119 | Parkinsons disease_Homo sapiens_hsa05012 | 0.37902214 |
| 120 | Glycosylphosphatidylinositol(GPI)-anchor biosynthesis_Homo sapiens_hsa00563 | 0.37473716 |
| 121 | Prostate cancer_Homo sapiens_hsa05215 | 0.37329027 |
| 122 | Tryptophan metabolism_Homo sapiens_hsa00380 | 0.35680114 |
| 123 | Thyroid cancer_Homo sapiens_hsa05216 | 0.34416920 |
| 124 | Notch signaling pathway_Homo sapiens_hsa04330 | 0.33634873 |
| 125 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.33480365 |
| 126 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.30141116 |
| 127 | Endocytosis_Homo sapiens_hsa04144 | 0.28655879 |
| 128 | Alzheimers disease_Homo sapiens_hsa05010 | 0.19912803 |
| 129 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.18055707 |
| 130 | Huntingtons disease_Homo sapiens_hsa05016 | 0.17382415 |
| 131 | Protein processing in endoplasmic reticulum_Homo sapiens_hsa04141 | 0.16719480 |
| 132 | Protein export_Homo sapiens_hsa03060 | 0.16158726 |

